TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: number of repetitions performed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: muscular fatigue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median worst pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful 1-year follow-up rate
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Intentions to limit serving children sugary drinks
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intentions to serve children more water
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of remitters at 6 months
Endpoint domain: Mortality/survival
Primary endpoint: Physical and psychological quality of life improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Proportion of patients staying in the ICU for less than 48 hours after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative insulin requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Episodes of VAS scores > 4 in the first 48 hours after surgery
Endpoint domain: Adverse events/effects
Primary endpoint: self-efficacy to use harm reduction strategies
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: disclosure of sexual violence during the visit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: creatinine urinary albumin creatinin ratio (UACR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Cardiovascular outcomes (blood pressure and pulse rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Residual urine volume changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Voided volume/micturition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: LOTCA score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Bristol stool score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Survival until hospital discharge without organ support
Endpoint domain: Mortality/survival
Primary endpoint: overall plaque scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of past 12-month substance use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of substance use disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disclosure rates on the TAPS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Implementation fidelity
Endpoint domain: Resource use
Primary endpoint: rehydration coefficient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: urea nitrogen levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: serum DAO activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: nutritional status indicators
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: ARDS within ten days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Median percent reduction in seizure frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Functional Endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptoms of prolonged grief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction with flexible duty-hours
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Duty-hour violations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fugl‐Meyer Assessment upper extremity subscale change scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Partial response rate in endometrial cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stable disease rate greater than 4 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of treatment-related grade 3/4 adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Mean rescue analgesic consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peripheral capillary oxygen saturation (SpO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain measured with the numeric rating scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: preparedness
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Mean global QOR-40 score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Month 12 VALS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ETDRS letter gains
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incomplete pulmonary vein isolation (PVI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: FSI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: HOMA2‐%S
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum gamma‐glutamyltransferase (GGT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pain scores in the postoperative period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum plasma JR-142 concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration-time curve (AUC0-τ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of GLP-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Levels of insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: well‐being survey scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: salivary oxytocin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of arrest
Endpoint domain: Mortality/survival
Primary endpoint: subsequent injury
Endpoint domain: Mortality/survival
Primary endpoint: Influence on insights into babies
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 30-day composite of all-cause mortality and renal replacement therapy
Endpoint domain: Mortality/survival
Primary endpoint: days alive without life support
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: smooth placement rate of the first endoscope insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of postoperative dizziness
Endpoint domain: Adverse events/effects
Primary endpoint: length of PACU stay
Endpoint domain: Resource use
Primary endpoint: success rate of pulpal anaesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration of anaesthetic effect of IANB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportions of patients with blood pressure below 140/95
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of remineralization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: auricular impression accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: death due to a fall
Endpoint domain: Mortality/survival
Primary endpoint: PR loss area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: primary cognitive outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daily sputum production
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Reduction of anger scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: complete tumor response rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Primary unassisted patency rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Mean Kt/V
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Average weekly pain reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total FSS score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: plasma CORT level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Rates of csPC detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: survival to the 90th vs. 60th percentile age
Endpoint domain: Mortality/survival
Primary endpoint: risk of cardiovascular diseases
Endpoint domain: Mortality/survival
Primary endpoint: Patient nutritional status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NPC measures reliability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: internal coherence
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Decrease in number of emergency eye service visits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence rates of high-severity eye pathologies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serious Infections (SIs) Incidence Rate
Endpoint domain: Adverse events/effects
Primary endpoint: Herpes Zoster (HZ) Incidence Rate
Endpoint domain: Adverse events/effects
Primary endpoint: Non-Herpes Zoster Opportunistic Infections (OIs) Incidence Rate
Endpoint domain: Adverse events/effects
Primary endpoint: total supplemental oxygen requirement from baseline to Day 14
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: requirement for supplemental oxygen for at least 24 hours by Day 14
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of large, least-dense LDL particles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cholesterol content of large HDL particles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total triglycerides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Emergence of nonsusceptibility to meropenem
Endpoint domain: Adverse events/effects
Primary endpoint: neck pain severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: caregiver strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: caregiver psychological aggression
Endpoint domain: Adverse events/effects
Primary endpoint: youth affect suppression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: hs-cTnT reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Predictive accuracy of aspiration risk models
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CLDEQ-8 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preliminary new HCV diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: VAS-FA score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: muscle strength deficits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: missed work days
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Quality-Adjusted Life Years (QALYs) gained
Endpoint domain: Physiological/clinical
Primary endpoint: rate of change in FVC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Doubling dose increase in methacholine PD20
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time to any recurrence (TTR)
Endpoint domain: Mortality/survival
Primary endpoint: Cumulative frequency of clinical pregnancy loss
Endpoint domain: Mortality/survival
Primary endpoint: gait decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive treatment response for victimization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total canine retraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radial diffusivity (RD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean diffusivity (MD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Intention to receive the vaccine
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clearance of lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean PLA score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decreased hyperactivity and inattention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative total mobilization time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration of wheezing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: alleviating coughing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Risk of preterm birth associated with plasma MMP-9 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of preterm birth associated with plasma MMP-2 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scalp pain perception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FEV1/FVC ratio improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of manic episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interleukin‐6 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FAR angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WOMAC subgroups improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global scores for videos with NNEA
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: LD exposures (Cmax0‐16, AUC0‐16 and AUC∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HF scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DNS scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MSSP scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: alpha rhythm in occipital leads
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: stabilization of affective symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: global functioning
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Retention at the 12-week endpoint
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Acceptable adherence to exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bilateral wrinkle improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TOTPAR4 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: analgesia for acute pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: minor adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: Conformity index of planning target volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of grade 2 or higher dermatitis
Endpoint domain: Adverse events/effects
Primary endpoint: Recurrent joint swelling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Total morphine given during the first 72 h post-operatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS scores during rest and activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean range of motion on post-operative days 1, 2, and 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in volume of the nasal dorsum and radix
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Elevation of the nasal dorsum and radix
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Low glucose concentrations (<47 mg/dL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of time in central glucose concentration range (54-72 mg/dL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: confidence in coping
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Need for mechanical ventilation support
Endpoint domain: Mortality/survival
Primary endpoint: accuracy of nodule shape approximation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: speed of nodule shape approximation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: freedom from AF
Endpoint domain: Mortality/survival
Primary endpoint: Transition readiness and appropriateness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean area of hyporeflectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete cytoreductive surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Sensitivity of BioFire assay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of BioFire assay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall medication error rate
Endpoint domain: Adverse events/effects
Primary endpoint: Median percentage of interventions performed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participants' agreement to use the checklist
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Postoperative quality of recovery (QoR-40 score)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: HADS-D scores (depression)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: First major adverse cardiovascular events (MACE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of cardiovascular events (CVEs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Participation in activities they enjoy
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: HLA‐DR expression in CD45+ conjunctival cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: ECG test scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of discomfort when answering sensitive questions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maximum percentage fall in FEV1 post-exercise challenge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percentage of subjects fully protected (maximum percentage fall in FEV1 < 10%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: QoR-15 total scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: NPI apathy score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants with no apathy symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alzheimer's Disease Cooperative Study Clinical Global Impression of Change
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cortical activation in response to somatosensory stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Postprandial hunger ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postprandial fullness AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levator hiatus area during Valsalva maneuver
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median ventilator-free days at Day 28
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion of children with folate deficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of IOP elevation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: mean leakage value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NRS (Numeric Rating Scale) during the first three postoperative days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes